Multidrug-Resistant Tuberculosis and Bedaquiline

被引：14
|
作者：
Salfinger, Max [1 ]
Somoskovi, Akos [2 ]
机构：
[1] Natl Jewish Hlth, Denver, CO 80206 USA
[2] Skaraborg Hosp, Skovde, Sweden
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2014年 / 371卷 / 25期
关键词：
D O I：
10.1056/NEJMc1412235
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2435 / 2436
页数：2
相关论文
共 50 条
  • [21] Bedaquiline: A Novel Antitubercular Agent for the Treatment of Multidrug-Resistant Tuberculosis
    Yadav, Sankalp
    Rawal, Gautam
    Baxi, Mudit
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2016, 10 (08) : FM1 - FM2
  • [22] Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence
    Pontali, Emanuele
    Sotgiu, Giovanni
    D'Ambrosio, Lia
    Centis, Rosella
    Migliori, Giovanni Battista
    EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (02) : 394 - 402
  • [23] Pharmacokinetics of bedaquiline, delamanid and clofazimine in patients with multidrug-resistant tuberculosis
    Alghamdi, Wael A.
    Al-Shaer, Mohammad H.
    Kipiani, Maia
    Barbakadze, Ketevan
    Mikiashvili, Lali
    Kempker, Russell R.
    Peloquin, Charles A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (04) : 1019 - 1024
  • [24] Bedaquiline-based treatment regimen for multidrug-resistant tuberculosis
    Olaru, Ioana D.
    Heyckendorf, Jan
    Andres, Soenke
    Kalsdorf, Barbara
    Lange, Christoph
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (05)
  • [25] New drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline
    Leibert, Eric
    Danckers, Mauricio
    Rom, William N.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 597 - 602
  • [26] Compassionate use of delamanid in combination with bedaquiline for the treatment of multidrug-resistant tuberculosis
    Hafkin, Jeffrey
    Hittel, Norbert
    Martin, Alexandra
    Gupta, Rajesh
    EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (01)
  • [27] Bedaquiline in multidrug-resistant tuberculosis treatment: Safety and efficacy in a Korean subpopulation
    Kim, Ji Hyun
    Kwon, O. Jung
    Kim, Young Sam
    Park, Moo Suk
    Hwang, Sungchul
    Shim, Tae Sun
    RESPIRATORY INVESTIGATION, 2020, 58 (01) : 45 - 51
  • [28] Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis
    Cox, V
    Brigden, G.
    Crespo, R. H.
    Lessem, E.
    Lynch, S.
    Rich, M. L.
    Waning, B.
    Furin, J.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2018, 22 (04) : 407 - +
  • [29] Bedaquiline versus placebo for management of multidrug-resistant tuberculosis: A systematic review
    Singh, Surjit
    Sharma, Pramod Kumar
    Kaur, Rimplejeet
    INDIAN JOURNAL OF PHARMACOLOGY, 2016, 48 (04) : 466 - 466
  • [30] Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries
    Guglielmetti, L.
    Hewison, C.
    Avaliani, Z.
    Hughes, J.
    Kiria, N.
    Lomtadze, N.
    Ndjeka, N.
    Setkina, S.
    Shabangu, A.
    Sikhondze, W.
    Skrahina, A.
    Veziris, N.
    Furin, J.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2017, 21 (02) : 167 - 174
12345